Ovid Therapeutics Inc. Files Form 4 for Ownership Changes
Ticker: OVID · Form: 4 · Filed: Apr 9, 2026 · CIK: 0001636651
| Field | Detail |
|---|---|
| Company | Ovid Therapeutics Inc. (OVID) |
| Form Type | 4 |
| Filed Date | Apr 9, 2026 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: insider-transaction, ownership-change, form-4
Related Tickers: OVID
TL;DR
Ovid Therapeutics (OVID) insiders filed a Form 4 on 4/9/26 showing ownership changes from 4/7/26.
AI Summary
On April 9, 2026, Ovid Therapeutics Inc. filed a Form 4, reporting changes in beneficial ownership of securities. Stelios Papadopoulos, a reporting person, made transactions related to Ovid Therapeutics Inc. The filing details transactions that occurred on April 7, 2026.
Why It Matters
Form 4 filings are crucial for investors as they disclose changes in stock ownership by company insiders, providing insights into their confidence in the company's prospects.
Risk Assessment
Risk Level: low — This filing is a routine disclosure of insider stock transactions and does not inherently indicate significant risk.
Key Numbers
- 2026-04-09 — Filing Date (Date the Form 4 was filed with the SEC.)
- 2026-04-07 — Period of Report (Date of the reported stock transactions.)
Key Players & Entities
- Ovid Therapeutics Inc. (company) — Issuer
- Stelios Papadopoulos (person) — Reporting Person
- 0001636651 (company) — Ovid Therapeutics Inc. CIK
- 0001202098-26-000004 (document) — SEC Accession Number
FAQ
What type of filing is this?
This is a Form 4 - Statement of changes in beneficial ownership of securities.
Who is the issuer?
The issuer is Ovid Therapeutics Inc. (CIK: 0001636651).
When was the filing accepted by the SEC?
The filing was accepted on 2026-04-09 at 17:15:09.
Who is listed as a reporting person?
Stelios Papadopoulos is listed as a reporting person.
What is the period of report for the transactions?
The period of report for the transactions is 2026-04-07.
Filing Details
This Statement of Changes in Beneficial Ownership (Form 4) was filed with the SEC on April 9, 2026 by Stelios Papadopoulos regarding Ovid Therapeutics Inc. (OVID). Form 4 filings disclose purchases, sales, or other changes in ownership by company insiders such as officers, directors, and major shareholders.